India, Sept. 30 -- Indian manufacturers across pharmaceuticals, chemicals and engineering could see changes in the competitive environment as the government steps up scrutiny of potentially dumped imports. The Directorate General of Trade Remedies (DGTR) has initiated multiple investigations covering products imported from China and other countries. If the probes eventually result in trade remedies, domestic manufacturers could face lower import pressure, making select listed companies relevant for investors tracking this theme.

Fresh Anti-Dumping Probes An anti-dumping case on seven products from China has been filed by India in reaction to grievances from local manufacturing firms. The products range from pharmaceuticals, chemicals, a...